What are the New Guidelines for AI-QCPA in Cardiology?
In a recent episode of the SCCT’s Donut of Destiny podcast, cardiovascular imaging expert Dr. Ron Blankstein breaks down how new scientific statements from the ACC, AHA, and The Lancet are redefining the use of Artificial Intelligence in Quantitative Coronary Plaque Analysis (AI-QCPA).
Key Takeaways from the Podcast
If you are a cardiologist or imaging specialist looking to stay up-to-date on AI in cardiovascular imaging, this 38-minute episode covers the most critical updates in the field. Host Praveen Ranganath and Dr. Blankstein explore the clinical implications of three major publications:
- • The ACC Scientific Statement on Quantitative Coronary Plaque Analysis (QCPA).
- • The AHA Scientific Statement on Nonobstructive Coronary Artery Disease (CAD).
- • The Lancet Commission on Rethinking Coronary Artery Disease.
Why are these new AI-QCPA statements important?
Artificial intelligence is rapidly transforming how we analyze coronary artery disease. These new consensus statements provide much-needed standards and clinical guidelines for the use of advanced plaque analysis tools, ensuring providers can use AI safely and effectively in patient care.
About Dr. Ron Blankstein
Dr. Blankstein is a prominent opinion leader and expert in preventive cardiology and imaging. In this episode, he lends his expertise to help practitioners understand how to apply these new complex guidelines in real-world clinical settings.
Where can I listen to the episode?
You can stream the full episode, “How New Statements Are Redefining AI-QCPA,” below, directly on the Donut of Destiny website, or wherever you get your podcasts (including Apple Podcasts and Spotify).
